Document Detail


Methods to increase the success rate of artificial insemination with donor semen.
MedLine Citation:
PMID:  8046019     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Donor insemination was performed in two fertility clinics using cryopreserved semen from the same sperm bank. Donors were selected in agreement with American Fertility Society recommendations. In the first clinic, cup insemination was combined with intra-uterine insemination in 321 cycles. Follicular development was closely monitored with vaginal echography and serum hormonal measurements. In the second clinic, 1287 insemination cycles were performed using intra-cervical insemination, timed only on basal body temperature. In the first clinic, a total of 53 pregnancies were obtained, of which seven were in 55 unstimulated cycles (12.5%), 21 in 159 cycles with clomiphene citrate stimulation (13.1%, P > 0.1), and 25 in 107 cycles stimulated with clomiphene plus human menopausal gonadotrophin (HMG) (23.9%, P < 0.03). No multiple pregnancies were observed in the latter group. In the second clinic, 159 pregnancies occurred during 1287 insemination cycles (12.4%). It is concluded that neither intra-uterine insemination, nor hormonal and echographic cycle monitoring, nor clomiphene citrate enhances the success rate of artificial insemination with donor semen, but HMG treatment probably exerts a favourable effect.
Authors:
H T Depypere; S Gordts; R Campo; F Comhaire
Related Documents :
11779599 - Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating h...
1612529 - Measurement of noradrenaline, dopamine and serotonin contents in follicular fluid of hu...
11109969 - The use of a starting dose of recombinant follicle stimulating hormone for controlled o...
1601149 - The outcome of in vitro fertilization and embryo transfer in women with polycystic ovar...
20053149 - Acupuncture and herbal medicine in in vitro fertilisation: a review of the evidence for...
19200979 - Gonadotropin-releasing hormone antagonist use in controlled ovarian stimulation and int...
7819009 - Fetal renal maldevelopment with oligohydramnios following maternal use of piroxicam.
3535159 - Cellular localisation in placenta of placental type plasminogen activator inhibitor.
20695679 - Hope!
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Human reproduction (Oxford, England)     Volume:  9     ISSN:  0268-1161     ISO Abbreviation:  Hum. Reprod.     Publication Date:  1994 Apr 
Date Detail:
Created Date:  1994-09-01     Completed Date:  1994-09-01     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8701199     Medline TA:  Hum Reprod     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  661-3     Citation Subset:  IM    
Affiliation:
Department of Gynaecology, University Hospital, Ghent, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Age Factors
Clomiphene / therapeutic use
Cryopreservation
Estradiol / blood
Female
Humans
Infertility, Male
Insemination, Artificial, Heterologous*
Male
Menotropins / therapeutic use
Ovarian Follicle / physiology,  ultrasonography
Pregnancy
Semen*
Semen Preservation
Sperm Motility
Chemical
Reg. No./Substance:
50-28-2/Estradiol; 61489-71-2/Menotropins; 911-45-5/Clomiphene

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human oviductal cells and their conditioned medium maintain the motility and hyperactivation of huma...
Next Document:  The effect of some proteinase inhibitors on liquefaction of human semen.